BEAM·07373V105·US·equity·Healthcare - Biotechnology-13D/G
BEAM (BEAM THERAPEUTICS INC) is held by 119 institutional investors as of Q1 2026. Largest holders: FMR LLC ($296.7M), ARK Investment Management LLC ($289.1M), FARALLON CAPITAL MANAGEMENT LLC ($241.5M). Net institutional sentiment: Mixed.
See how BEAM's score breaks down across 4 SEC sources
Showing 1-20 of 138
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer